A Web-Based Study of the Relationship of Duration of Insulin Pump Infusion Set Use and Fasting Blood Glucose Level in Adults with Type 1 Diabetes

Diabetes Technology and Therapeutics

Volumn 17, Issue 5, 2015, Pages 307-310

  Sampson Perrin, Alysa J ^a   Guzzetta, Russell C ^a   Miller, Kellee M ^a   Foster, Nicole C ^a   Lee, Anna ^b   Lee, Joyce M ^c   Block, Jennifer M ^d   Beck, Roy W ^a  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b Unitio   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN GLULISINE; INSULIN LISPRO; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ADULT DISEASE; ARTICLE; BLOOD GLUCOSE METER; DIABETIC PATIENT; DISEASE DURATION; ENDOCRINE PANCREAS FUNCTION TEST; FASTING GLUCOSE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCOME; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN GLULISINE DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INTERNET; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; TREATMENT DURATION; YOUNG ADULT; ADOLESCENT; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 1; DIET RESTRICTION; DOSE RESPONSE; FEASIBILITY STUDY; INFORMATION PROCESSING; PROCEDURES; QUESTIONNAIRE; TIME; UTILIZATION;

ADOLESCENT; ADULT; BLOOD GLUCOSE; DATA COLLECTION; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; FASTING; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; INTERNET; MALE; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 84934279466     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0336     Document Type: Article

References (9)

1. Frid A, Hirsch L, Gaspar R, et al.: New injection recommendations for patients with diabetes. Diabetes Metab 2010; 36(Suppl 2):S3-18.
2. Frid A, Hirsch L, Gaspar R, et al.: The Third Injection Technique Workshop in Athens (TITAN). Diabetes Metab 2010;36(Suppl 2):S19-S29.
3. Heinemann L, Krinelke L: Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion. J Diabetes Sci Technol 2012;6:954-964.
4. Phillip M, Battelino T, Rodriguez H, et al.: Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007;30:1653-1662.
5. Scheiner G, Sobel RJ, Smith DE, et al.: Insulin pump therapy: guidelines for successful outcomes. Diabetes Educ 2009;35(Suppl 2):29S-41S; quiz 28S, 42S-43S.
6. Schmid V, Hohberg C, Borchert M, et al.: Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3. J Diabetes Sci Technol 2010;4:976-982.
7. Scheiner G, Sage D, Wolff P, et al.: Insulin Pump Therapy: Best Practices in Choosing and Using Infusion Devices. Chicago: American Association of Diabetes Educators, 2011.
8. Thethi TK, Rao A, Kawji H, et al.: Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion. J Diabetes Complications 2010;24:73-78.
9. Beck RW, Tamborlane WV, Bergenstal RM, et al.: The T1D Exchange Clinic Registry. J Clin Endocrinol Metab 2012; 97:4383-4389.